| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |